ENORAMA PHARMA AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.09 SEK | +8.04% |
|
+3.00% | -0.32% |
| May. 22 | Enorama Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Feb. 28 | Intervacc's Acting CEO Assumes Role Permanently | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 3.190 | 4.420 | 3.980 |
| Spread/Res. | -3.13% | -30.09% | -22.36% |
| Spread/Supp. | +14.87% | +43.06% | +36.12% |
| Support | 2.690 | 2.160 | 2.270 |
- Stock Market
- Equities
- ERMA Stock
- Charts Enorama Pharma AB
